卵巢反应与GnRH拮抗剂IVF/ICSI周期不良围产结局是否相关
该回顾性单中心队列研究纳入2009年1月至2015年12月首次采用促性腺激素释放激素拮抗剂方案行卵巢刺激、新鲜胚胎移植并获单胎活产的964例患者,按获卵数分为1–3、4–9、10–15及>15四组。结果显示各组新生儿体重、早产、低出生体重及不良产科结局均无统计学显著差异,多因素回归显示获卵数与新生儿出生体重无关。作者结论为拮抗剂IVF/ICSI周期中卵巢反应与不良围产结局无关联,需未来更大规模前瞻性研究验证。
要点
- 按获卵数1–3、4–9、10–15及>15分为四组,共964例单胎活产。
- 四组新生儿体重分别为3222±607、3254±537、3235±575、3200±622克,P=0.85。
- 早产与低出生体重的发生率组间比较P=0.127与P=0.19。
核心结论
- 拮抗剂IVF/ICSI周期中未发现卵巢反应与不良围产结局存在关联。
- 作者指出需未来更大规模、前瞻性设计的研究验证上述结果。
研究设计与样本
- 回顾性单中心队列研究,纳入2009年1月至2015年12月首次行促性腺激素释放激素拮抗剂方案卵巢刺激、新鲜胚胎移植并获单胎活产的全部女性。
- 按获卵数分为四组:1–3个(第1类)、4–9个(第2类)、10–15个(第3类)、超过15个(第4类)。
- 共分析964例患者。
主要发现
- 四组新生儿体重(克)分别为3222±607、3254±537、3235±575、3200±622,P=0.85(依次为第1、2、3、4类)。
- 考虑新生儿性别与分娩孕周后,四组出生体重z评分无统计学显著差异。
- 四组早产发生率比较P=0.127,低出生体重发生率比较P=0.19。
- 不良产科结局的发生率在各卵巢反应类别间无差异。
- 多因素回归分析显示获卵数与新生儿出生体重无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is there an association between ovarian response and perinatal outcomes? DESIGN: A retrospective, single-centre cohort study including all women undergoing their first ovarian stimulation cycle in a gonadotrophin releasing hormone antagonist protocol, with a fresh embryo transfer that resulted in a singleton live birth from January 2009 to December 2015. Patients were categorized into four groups according to the number of oocytes retrieved: one to three (category 1), four to nine (category 2), 10-15 (category 3), or over 15 oocytes (category 4). RESULTS: The overall number of patients analysed was 964. No relevant statistical difference was found among neonatal outcomes across the four ovarian response categories. Neonatal weight (in grams) was comparable between all groups (3222 ± 607 versus 3254 ± 537 versus 3235 ± 575 versus 3200 ± 622; P = 0.85, in categories 1, 2, 3 and 4, respectively). No statistically significant differences were found among the ovarian response categories for birth weight z-scores (taking into account neonatal sex and delivery term). The incidence of pre-term birth and low birth weight was comparable across the different ovarian response groups (P = 0.127 and P = 0.19, respectively). Finally, the occurrence of adverse obstetric outcomes did not differ among the ovarian response categories. Multivariate regression analysis revealed that the number of oocytes was not associated with neonatal birth weight. CONCLUSIONS: No association was found between ovarian response and adverse perinatal outcomes in antagonist IVF and intracytoplasmic sperm injection cycles. Future, larger scale and prospectively designed investigations are needed to validate these results.
引用
- Bardhi E, Blockeel C, Cools W, et al. Is ovarian response associated with adverse perinatal outcomes in GnRH antagonist IVF/ICSI cycles? Reprod Biomed Online. 2020. PMID: 32505544. doi:10.1016/j.rbmo.2020.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。